Sonnet BioTherapeutics Holdings, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
SONN on Nasdaq
Location
100 Overlook Center, Suite 102, Princeton, NJ

There are no Buy or Sell transactions made by insiders since 10/15/2024

Sonnet BioTherapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Markey 10%+ Owner $198K Aug 7, 2023
Raghu Rao Interim CEO, Director $29.7K Jul 11, 2025
John K. Cini Chief Scientific Officer $18.8K Jul 11, 2025
Pankaj Mohan Chairman, President and CEO, Director $16.3K Dec 11, 2023
Nailesh Bhatt Director $14K Jul 11, 2025
Donald J. Griffith Chief Financial Officer, Director $13.8K Jul 11, 2025
Susan Dexter Chief Technical Officer $12.8K Jul 11, 2025
Richard T. Kenney Chief Medical Officer $12.5K Jul 11, 2025
Stephen J. Mcandrew Chief Business Officer $8.57K Jul 11, 2025
Albert D. Dyrness Director $6.03K Jul 11, 2025
Lori McNeill Director $5.84K Jul 11, 2025
John Harry Cross III Chief Financial Officer $1.68K Dec 11, 2023

Recent Insider Transactions by Companies or Individuals for Sonnet BioTherapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.